Table 2: Distribution of isolates.
| Organisms |
Total isolates |
No. of MDR strains |
ESBL screening positive |
ESBL confirmed |
| E. coli |
365(80.9%) |
188(79.7%) |
160 |
33 (91.7%) |
| K. oxytoca |
3 (0.7%) |
1(0.4%) |
1 |
0 (0%) |
| K. pneumoniae |
17(3.8%) |
8(3.4%) |
7 |
3 (8.3%) |
|
Acinetobacter spp |
1 (0.2%) |
0 (0%) |
NT |
NT |
|
Citrobacter spp |
4 (0.9%) |
1 (0.4%) |
NT |
NT |
|
Enterobacter spp |
3 (0.7%) |
1 (0.4%) |
NT |
NT |
|
Enterococcus spp |
3 (0.7%) |
2 (0.8%) |
NT |
NT |
|
Morganella spp |
3 (0.7%) |
1 (0.4%) |
NT |
NT |
| Proteus mirabilis |
12 (2.7%) |
7 (3%) |
NT |
NT |
| Proteus vulgaris |
7 (1.6%) |
6 (2.5%) |
NT |
NT |
|
Providencia spp |
22 (4.9%) |
12 (5.1%) |
NT |
NT |
|
Pseudomonas spp |
7 (1.6%) |
7 (3%) |
NT |
NT |
|
Staphylococcus spp |
4 (0.9%) |
2 (0.8%) |
NT |
NT |
| Total |
451 (100%) |
236 (100%) |
168 |
36 (100%) |
NT=not tested